Stem Cell Therapy Market, US, 2005-2016: do you believe this?

This extrapolation is from the inforich and insider Stem Cell Market Analysis Fact Sheet of the 2nd Annual Stem Cell Summit, February 12-13 at San Diego, happening now.


Other important facts concerning the Stem Cell Therapy Market in the U.S.:

o Number of patients treated in 2006 the United States with stem cell products for orthopedic, cardiovascular, dental, aesthetic, oncologic or other indications: 5,900

• Current Applications for Stem Cell Products
o Replacement for bone harvesting in spine fusion surgery
o Bone growth and void fill in fresh fractures
o Bone growth and void fill in non-union fractures

• Stem Cell Products Expected to be Approved by the FDA in the Coming 36 Months
o Prochymal (treatment for graft vs. host disease)
o Two (possibly three) treatments for damaged heart muscle due to heart disease
o Chondrogen (repair of knee cartilage)

• Market for Stem Cell Products
o Patient population in the United States for whom existing stem cell therapies are applicable: 2.5 million +

13 thoughts on “Stem Cell Therapy Market, US, 2005-2016: do you believe this?

  1. I believe the growth rate will be a lot less even, and will not go under 100% AGT as it is shown after 2010, quite on the contrary – once stem cell therapy reaches mums on a grand scale. What I see as a potential and very rough future scenario (maybe naive) is the following:
    there will be a huge media wave, followed by a striking upsurge in demand, and, simulatenously, a rush to develop the necessary infrastructure for stem cell therapy (also the administrative background).
    Media wave is bound to reach mothers, and, I guess, mums are strong decision-makers in family health business (at least in Hungary, and in several European countries) just like in shopping.

  2. You can buy the full report at for a mere $2,995.00. Looks like they’ve pulled the PDF Attila linked to.

  3. Yeah, it was a horrible sum and the pdf was eliminated. I’ll blog one more interesting part of it, on the major stem cell companies in the U.S. with many additional infos. I got the permission. 🙂

  4. Hi,

    I would like to cite the above market data on stem cell applications, as well as the number of 5900 patients treated with such therapies in 2006 in the US, in a paper I am writing on a work I did with stem cells. Would anybody know what exactly the source of the above data is?
    I would definitely appreciate your reply / help. Regards from Germany,


  5. I said this 7 years ago, and no one listened.

    You all are sheep, looking for magic leaders, and guess what?

    They are lying to you.

  6. Jonas:

    That would be “what the above data are?”
    In any event, does it matter? Stem cell therapy doesn’t work and shows no sign of working any time soon.

Comments are closed.